Clinical trial
Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary…
NCT00168116 · AHS Cancer Control Alberta, Other · Completed
Key facts
| NCT number | NCT00168116 |
|---|---|
| Title | Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure |
| Official title | To Evaluate the Effects of Transfer of Submandibular Salivary Gland to the Submental Region (Outside the Radiation Field) on Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure |
| Lead sponsor | AHS Cancer Control Alberta, Other |
| Collaborators | Cross Cancer Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Procedure |
| Interventions | radiation treatment and surgery, radiation alone |
| Enrollment | 42 |
| Start date | Jul 1, 2000 |
| Primary completion | May 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 24, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: